Journal of Thoracic Oncology, volume 20, issue 3, pages e47-e48

Artificial Intelligence Technologies for Managing High-Risk Patients With Immune-Related Adverse Events and Optimizing Timing

Fangjie Liu
, 
Hui Li
Publication type: Journal Article
Publication date: 2025-03-04
scimago Q1
wos Q1
SJR: 7.879
CiteScore: 36.0
Impact factor: 21
ISSN: 15560864, 15561380
Found 

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Share
Cite this
GOST |
Cite this
GOST Copy
Liu F., Li H. Artificial Intelligence Technologies for Managing High-Risk Patients With Immune-Related Adverse Events and Optimizing Timing // Journal of Thoracic Oncology. 2025. Vol. 20. No. 3. p. e47-e48.
GOST all authors (up to 50) Copy
Liu F., Li H. Artificial Intelligence Technologies for Managing High-Risk Patients With Immune-Related Adverse Events and Optimizing Timing // Journal of Thoracic Oncology. 2025. Vol. 20. No. 3. p. e47-e48.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.jtho.2024.08.004
UR - https://linkinghub.elsevier.com/retrieve/pii/S1556086424007597
TI - Artificial Intelligence Technologies for Managing High-Risk Patients With Immune-Related Adverse Events and Optimizing Timing
T2 - Journal of Thoracic Oncology
AU - Liu, Fangjie
AU - Li, Hui
PY - 2025
DA - 2025/03/04
PB - Elsevier
SP - e47-e48
IS - 3
VL - 20
SN - 1556-0864
SN - 1556-1380
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2025_Liu,
author = {Fangjie Liu and Hui Li},
title = {Artificial Intelligence Technologies for Managing High-Risk Patients With Immune-Related Adverse Events and Optimizing Timing},
journal = {Journal of Thoracic Oncology},
year = {2025},
volume = {20},
publisher = {Elsevier},
month = {mar},
url = {https://linkinghub.elsevier.com/retrieve/pii/S1556086424007597},
number = {3},
pages = {e47--e48},
doi = {10.1016/j.jtho.2024.08.004}
}
MLA
Cite this
MLA Copy
Liu, Fangjie, and Hui Li. “Artificial Intelligence Technologies for Managing High-Risk Patients With Immune-Related Adverse Events and Optimizing Timing.” Journal of Thoracic Oncology, vol. 20, no. 3, Mar. 2025, pp. e47-e48. https://linkinghub.elsevier.com/retrieve/pii/S1556086424007597.
Found error?